GlassScriptPhysician profile
Melanie J Eubanks
NPI 1780634386
$2,670.80
in general payments reported to CMS, 2019-2025
27 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $200 · 2021: $286 · 2022: $199 · 2023: $170 · 2024: $109 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,125 · Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,125.25 |
| Food and Beverage | $702.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,202.48 | 2025 | Motoband |
| Smith+Nephew, INC. | $277.55 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $220.64 | 2020-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $190.37 | 2021-2025 | Motoband, N/A |
| Horizon Therapeutics Plc | $99.62 | 2019-2022 | |
| Averitas Pharma INC. | $84.64 | 2024-2025 | Qutenza |
| Abbvie INC. | $70.17 | 2021-2025 | |
| Globus Medical, INC. | $64.07 | 2025 | Senza, Omnia |
| Nabriva Therapeutics, Plc | $60.94 | 2021-2022 | |
| Nevro Corp. | $55.53 | 2022-2023 | Senza |
| Melinta Therapeutics, LLC | $53.47 | 2019 | |
| Orthofix Medical, INC. | $32.10 | 2023 | Physio-Stim |
| Stryker Corporation | $29.42 | 2022 | |
| Cardiovascular Systems INC. | $20.47 | 2020 | |
| Hartmann USA, INC. | $19.75 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.59 | 2022 | |
| Zimmer Biomet Holdings, INC. | $19.08 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.79 | 2020 | |
| Convatec INC. | $17.94 | 2023 | |
| Pfizer INC. | $17.93 | 2020 | |
| Abbott Laboratories | $15.47 | 2021 | |
| Bioventus LLC | $15.39 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.17 | 2023 | Seglentis |
| Novum Pharma, LLC | $13.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.12 | 2021 | |
| Triad Life Sciences INC. | $12.16 | 2022 | |
| Djo, LLC | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.